- Home
- LEGN vs SNEX Comparison
LEGN vs SNEX Comparison
Compare LEGN & SNEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LEGN | SNEX |
|---|---|---|
| Founded | 2014 | 1924 |
| Country | United States | United States |
| Employees | N/A | 5400 |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 6.7B |
| IPO Year | 2020 | 1996 |
Fundamental Metrics
Financial Performance| Metric | LEGN | SNEX |
|---|---|---|
| Price | $24.92 | $104.62 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 1 |
| Target Price | $63.08 | ★ $81.33 |
| AVG Volume (30 Days) | ★ 1.6M | 837.9K |
| Earning Date | 05-12-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.50 |
| Revenue | N/A | ★ $132,378,200,000.00 |
| Revenue This Year | $42.68 | N/A |
| Revenue Next Year | $30.52 | $4.17 |
| P/E Ratio | ★ N/A | $42.39 |
| Revenue Growth | N/A | ★ 32.53 |
| 52 Week Low | $16.24 | $68.97 |
| 52 Week High | $45.30 | $132.57 |
Technical Indicators
Market Signals| Indicator | LEGN | SNEX |
|---|---|---|
| Relative Strength Index (RSI) | 78.54 | 59.88 |
| Support Level | $17.01 | $94.67 |
| Resistance Level | $28.97 | $105.45 |
| Average True Range (ATR) | 1.21 | 3.71 |
| MACD | 0.63 | 3.30 |
| Stochastic Oscillator | 79.40 | 88.78 |
Price Performance
Historical ComparisonAbout LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
About SNEX StoneX Group Inc.
StoneX Group Inc is a brokerage and financial services firm. Its service offerings are execution, OTC / Market-Making, advisory services, payment solutions, market intelligence, Physical Trading and clearing services. The firm operates in four segments: Commercial, Institutional, Self-Directed/Retail, and Payments. Its customers include governmental and nongovernmental organizations, commercial banks, brokers, institutional investors, and investment banks. The company operates in the United States, South America, Europe, the Middle East and Asia, and other countries, out of which the majority of revenue is generated from the Middle East and Asia Region.